Home LiteratureArticle Details
PMID: 26669617 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma.

Gut ·Vol. 66 ·No. 2 ·2017-00-00 ·Pages 342-351

Garnelo M, Tan A, Her Z, Yeong J, Lim CJ, Chen J, Lim KH, Weber A, Chow P, Chung A, Ooi LL, Toh HC, Heikenwalder M, Ng IO, Nardin A, Chen Q, Abastado JP, Chew V

Abstract

The nature of the tumour-infiltrating leucocytes (TILs) is known to impact clinical outcome in carcinomas, including hepatocellular carcinoma (HCC). However, the role of tumour-infiltrating B cells (TIBs) remains controversial. Here, we investigate the impact of TIBs and their interaction with T cells on HCC patient prognosis. Tissue samples were obtained from 112 patients with HCC from Singapore, Hong Kong and Zurich and analysed using immunohistochemistry and immunofluorescence. RNA expression of CD19, CD8A, IFNG was analysed using quantitative PCR. The phenotype of freshly isolated TILs was analysed using flow cytometry. A mouse model depleted of mature B cells was used for functional study. Tumour-infiltrating T cells and B cells were observed in close contact with each other and their densities are correlated with superior survival in patients with HCC. Furthermore, the density of TIBs was correlated with an enhanced expression of granzyme B and IFN-γ, as well as with reduced tumour viability defined by low expression of Ki-67, and an enhanced expression of activated caspase-3 on tumour cells. CD27 and CD40 costimulatory molecules and TILs expressing activation marker CD38 in the tumour were also correlated with patient survival. Mice depleted of mature B cells and transplanted with murine hepatoma cells showed reduced tumour control and decreased local T cell activation, further indicating the important role of B cells. The close proximity of tumour-infiltrating T cells and B cells indicates a functional interaction between them that is linked to an enhanced local immune activation and contributes to better prognosis for patients with HCC.

Keywords
B CELL CANCER IMMUNOBIOLOGY HEPATOCELLULAR CARCINOMA IMMUNOREGULATION T LYMPHOCYTES
MeSH Terms
ADP-ribosyl Cyclase 1/analysis Adult Aged Aged, 80 and over Animals Antigens, CD/analysis Antigens, CD19/genetics Antigens, CD20/analysis B-Lymphocytes/chemistry,immunology,pathology CD3 Complex/analysis CD40 Antigens/analysis CD8 Antigens/analysis,genetics Carcinoma, Hepatocellular/chemistry,immunology,pathology Caspase 3/analysis Disease Progression Female Gene Expression Granzymes/analysis Humans Interferon-gamma/genetics Ki-67 Antigen/analysis Liver Neoplasms/chemistry,immunology,pathology Lymphocyte Depletion Lymphocytes, Tumor-Infiltrating Male Mice Mice, Inbred C57BL Middle Aged Phenotype Retrospective Studies Survival Rate T-Lymphocytes/chemistry,immunology,pathology Tumor Necrosis Factor Receptor Superfamily, Member 7/analysis Young Adult
Chemicals
Antigens, CD Antigens, CD19 Antigens, CD20 CD3 Complex CD40 Antigens CD8 Antigens CD8 antigen, alpha chain Ki-67 Antigen Tumor Necrosis Factor Receptor Superfamily, Member 7 Interferon-gamma ADP-ribosyl Cyclase 1 Granzymes Caspase 3
Authors & Affiliations
18 authors, click to expand affiliations / ORCID
Garnelo Marta
Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
Tan Alex
Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
Her Zhisheng
Institute of Molecular and Cell Biology (IMCB), A*STAR, Biopolis, Singapore.
Yeong Joe
Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore. | Department of Pathology, Singapore General Hospital, Singapore, Singapore.
Lim Chun Jye
SingHealth Translational Immunology and Inflammation Centre (STIIC), Singapore Health Services Pte Ltd, Singapore, Singapore.
Chen Jinmiao
Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
Lim Kiat Hon
Department of Pathology, Singapore General Hospital, Singapore, Singapore.
Weber Achim
Institute of Surgical Pathology, University Hospital of Zurich, Zurich, Switzerland.
Chow Pierce
National Cancer Centre, Singapore, Singapore. | Singapore General Hospital, Singapore, Singapore. | Duke-NUS Graduate Medical School, Singapore, Singapore.
Chung Alexander
National Cancer Centre, Singapore, Singapore. | Singapore General Hospital, Singapore, Singapore.
Ooi London Lucien Pj
National Cancer Centre, Singapore, Singapore. | Singapore General Hospital, Singapore, Singapore. | Duke-NUS Graduate Medical School, Singapore, Singapore.
Toh Han Chong
National Cancer Centre, Singapore, Singapore.
Heikenwalder Mathias
Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. | Institute of Virology, Technical University München/Helmholtz Zentrum München, Germany.
Ng Irene O L
Department of Pathology, The University of Hong Kong, Queen Mary Hospital, Hong Kong, Hong Kong. | State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong, Hong Kong.
Nardin Alessandra
Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore.
Chen Qingfeng
Institute of Molecular and Cell Biology (IMCB), A*STAR, Biopolis, Singapore. | National Cancer Centre, Singapore, Singapore.
Abastado Jean-Pierre
Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore. | Institut de Recherches Internationales Servier, Suresnes, France.
Chew Valerie
Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Biopolis, Singapore. | SingHealth Translational Immunology and Inflammation Centre (STIIC), Singapore Health Services Pte Ltd, Singapore, Singapore. | Duke-NUS Graduate Medical School, Singapore, Singapore.
Conflict of Interest

Conflicts of Interest: None declared.

References (40)
40 references, click to expand
  1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.
    Int J Cancer. 2015 Mar 1;136(5):E359-86 PMID: 25220842
  2. CD27 and CD70 in T cell and B cell activation.
    Curr Opin Immunol. 2005 Jun;17(3):275-81 PMID: 15886117
  3. Immune infiltration in human tumors: a prognostic factor that should not be ignored.
    Oncogene. 2010 Feb 25;29(8):1093-102 PMID: 19946335
  4. Agonist anti-human CD27 monoclonal antibody induces T cell activation and tumor immunity in human CD27-transgenic mice.
    J Immunol. 2013 Oct 15;191(8):4174-83 PMID: 24026078
  5. The role of CD40 ligand in costimulation and T-cell activation.
    Immunol Rev. 1996 Oct;153:85-106 PMID: 9010720
  6. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
    Gut. 2012 Dec;61(12):1733-43 PMID: 22267597
  7. CD20+ B cells: the other tumor-infiltrating lymphocytes.
    J Immunol. 2010 Nov 1;185(9):4977-82 PMID: 20962266
  8. The role of CD4 T cell help for CD8 CTL activation.
    Biochem Biophys Res Commun. 2009 Jul 10;384(4):405-8 PMID: 19410556
  9. Timing and tuning of CD27-CD70 interactions: the impact of signal strength in setting the balance between adaptive responses and immunopathology.
    Immunol Rev. 2009 May;229(1):216-31 PMID: 19426224
  10. OMIP-003: phenotypic analysis of human memory B cells.
    Cytometry A. 2011 Nov;79(11):894-6 PMID: 21796774
  11. Inhibitory Receptors Beyond T Cell Exhaustion.
    Front Immunol. 2015 Jun 26;6:310 PMID: 26167163
  12. CD38 is expressed selectively during the activation of a subset of mature T cells with reduced proliferation but improved potential to produce cytokines.
    J Leukoc Biol. 2005 Apr;77(4):513-21 PMID: 15618297
  13. The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging.
    J Clin Invest. 2013 Dec;123(12):5098-103 PMID: 24177426
  14. CD8 T cell priming by B lymphocytes is CD4 help dependent.
    Eur J Immunol. 2005 May;35(5):1360-70 PMID: 15816014
  15. Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis.
    Nat Med. 2015 Sep;21(9):998-1009 PMID: 26236991
  16. Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of Tyramide signal amplification, multispectral imaging and multiplex analysis.
    Methods. 2014 Nov;70(1):46-58 PMID: 25242720
  17. CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation.
    Leukemia. 2005 Dec;19(12):2264-72 PMID: 16208411
  18. B regulatory cells in cancer.
    Trends Immunol. 2013 Apr;34(4):169-73 PMID: 23206438
  19. Costimulatory and coinhibitory receptors in anti-tumor immunity.
    Immunol Rev. 2009 May;229(1):126-44 PMID: 19426219
  20. Control of established melanoma by CD27 stimulation is associated with enhanced effector function and persistence, and reduced PD-1 expression of tumor infiltrating CD8(+) T cells.
    J Immunother. 2010 Oct;33(8):769-79 PMID: 20842060
  21. Advances in human B cell phenotypic profiling.
    Front Immunol. 2012 Oct 10;3:302 PMID: 23087687
  22. CD38 expression and functional activities are up-regulated by IFN-gamma on human monocytes and monocytic cell lines.
    J Leukoc Biol. 2001 Apr;69(4):605-12 PMID: 11310847
  23. CD27-CD70 interactions regulate B-cell activation by T cells.
    Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11249-53 PMID: 7479974
  24. Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists.
    Clin Exp Immunol. 2009 Jul;157(1):9-19 PMID: 19659765
  25. Signaling through CD38 induces NK cell activation.
    Int Immunol. 2001 Apr;13(4):397-409 PMID: 11282979
  26. CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.
    Clin Cancer Res. 2012 Jun 15;18(12):3281-92 PMID: 22553348
  27. CD40-CD40 ligand interaction between dendritic cells and CD8+ T cells is needed to stimulate maximal T cell responses in the absence of CD4+ T cell help.
    J Immunol. 2007 Mar 1;178(5):2844-52 PMID: 17312128
  28. CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitis.
    J Virol. 2012 Mar;86(5):2416-27 PMID: 22205741
  29. The use of agonistic anti-CD40 therapy in treatments for cancer.
    Int Rev Immunol. 2012 Aug;31(4):246-66 PMID: 22804570
  30. Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients.
    J Hepatol. 2010 Mar;52(3):370-9 PMID: 19720422
  31. Role of CD27/CD70 pathway of activation in immunity and tolerance.
    J Leukoc Biol. 2011 Feb;89(2):195-203 PMID: 20699361
  32. Memory B cells.
    Nat Rev Immunol. 2015 Mar;15(3):149-59 PMID: 25677494
  33. Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma.
    Gut. 2012 Mar;61(3):427-38 PMID: 21930732
  34. Analysis and validation of tissue biomarkers for renal cell carcinoma using automated high-throughput evaluation of protein expression.
    Hum Pathol. 2014 May;45(5):1092-9 PMID: 24746216
  35. Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway.
    Cancer Lett. 2014 Dec 28;355(2):264-72 PMID: 25301451
  36. Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity.
    Exp Biol Med (Maywood). 2011 May 1;236(5):567-79 PMID: 21486861
  37. TIGIT and CD226: tipping the balance between costimulatory and coinhibitory molecules to augment the cancer immunotherapy toolkit.
    Cancer Cell. 2014 Dec 8;26(6):785-7 PMID: 25490444
  38. Decreased CD27 on B lymphocytes in patients with primary hepatocellular carcinoma.
    J Int Med Res. 2012;40(1):307-16 PMID: 22429370
  39. Lineage relationship and protective immunity of memory CD8 T cell subsets.
    Nat Immunol. 2003 Mar;4(3):225-34 PMID: 12563257
  40. Molecular pathways: the complex roles of inflammation pathways in the development and treatment of liver cancer.
    Clin Cancer Res. 2013 Jun 1;19(11):2810-6 PMID: 23549874
Article Info
Journal
Gut
Abbr.
Gut
ISSN
1468-3288
Published
2017-00-00
Epub
2015-00-15
Pages
342-351
Language
English
Region
England
NLM ID
2985108R
PMCID
PMC5284473
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com